These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 923186)

  • 21. Bioavailability and pharmacokinetics of phenytoin during pregnancy.
    Lander CM; Smith MT; Chalk JB; de Wytt C; Symoniw P; Livingstone I; Eadie MJ
    Eur J Clin Pharmacol; 1984; 27(1):105-10. PubMed ID: 6489420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable-isotope methodology for the bioavailability study of phenytoin during multiple-dosing regimens.
    Kasuya Y; Mamada K; Baba S; Matsukura M
    J Pharm Sci; 1985 May; 74(5):503-7. PubMed ID: 4020625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampicin reduces effectiveness and bioavailability of prednisolone.
    McAllister WA; Thompson PJ; Al-Habet SM; Rogers HJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):923-5. PubMed ID: 6403136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inability of ibuprofen to alter single dose phenytoin disposition.
    Bachmann KA; Schwartz JI; Forney RB; Jauregui L; Sullivan TJ
    Br J Clin Pharmacol; 1986 Feb; 21(2):165-9. PubMed ID: 3954932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma.
    Hutson TE; Ganapathi R; Elson P; Mekhail T; Olencki T; Budd GT; Bukowski RM
    Invest New Drugs; 2004 Aug; 22(3):277-84. PubMed ID: 15122074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diphenylhydantoin inhibits cortisol-induced lysis of thymocytes.
    MacKinney AA; Knobeloch L
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):474-7. PubMed ID: 3488552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of diphenylhydantoin on the bioavailability of citrus folate.
    Nelson EW; Cerda JJ; Wilder BJ; Streiff RR
    Am J Clin Nutr; 1978 Jan; 31(1):82-7. PubMed ID: 619607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism.
    Frey FJ; Frey BM
    J Lab Clin Med; 1983 Apr; 101(4):593-604. PubMed ID: 6833830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.
    Loughnan PM; Greenwald A; Purton WW; Aranda JV; Watters G; Neims AH
    Arch Dis Child; 1977 Apr; 52(4):302-9. PubMed ID: 871217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diphenylhydantoin intoxication following the exchange of seemingly equal DPH-preparations (author's transl)].
    Klingler D; Nitsche V; Schmidbauer H
    Wien Med Wochenschr; 1981; 131(11):295-300. PubMed ID: 6789561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5,5'-Diphenylhydantoin (phenytoin) attenuates the action of 3,5,3'-triiodo-L-thyronine in cultured GC cells.
    Gingrich SA; Smith PJ; Shapiro LE; Surks MI
    Endocrinology; 1985 Jun; 116(6):2306-13. PubMed ID: 3996315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5,5'-Diphenylhydantoin (dilantin) decreases cytosol and specific nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary in vivo and in cultured GC cells.
    Smith PJ; Surks MI
    Endocrinology; 1984 Jul; 115(1):283-90. PubMed ID: 6734517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men.
    Crowley JJ; Cusack BJ; Jue SG; Koup JR; Park BK; Vestal RE
    J Pharmacol Exp Ther; 1988 May; 245(2):513-23. PubMed ID: 3367304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum diphenylhydantoin in epileptic patients (preliminary report)].
    Radzikowska B; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1977; 11(5):551-4. PubMed ID: 593505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diurnal variation in prednisolone kinetics.
    English J; Dunne M; Marks V
    Clin Pharmacol Ther; 1983 Mar; 33(3):381-5. PubMed ID: 6681739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose.
    McAllister WA; Winfield CR; Collins JV
    Eur J Clin Pharmacol; 1981; 20(2):141-5. PubMed ID: 7262175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loading and conventional dose therapy with phenytoin in children: kinetic profile of parent drug and main metabolite in plasma.
    Wilson JT; Höjer B; Rane A
    Clin Pharmacol Ther; 1976 Jul; 20(1):48-58. PubMed ID: 132330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW
    Clin Pharmacol Ther; 1980 Feb; 27(2):170-8. PubMed ID: 7353335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of plasma exchange on phenytoin plasma concentration.
    Silberstein LE; Shaw LM
    Ther Drug Monit; 1986; 8(2):172-6. PubMed ID: 3726930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure.
    Borgå O; Hoppel C; Odar-Cederlöf I; Garle M
    Clin Pharmacol Ther; 1979 Sep; 26(3):306-14. PubMed ID: 466924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.